Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isavuconazole Prophylaxis in Allogeneic HCT
NCT03149055Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isavuconazole in invasive fungal infection (IFI), sponsored by Memorial Sloan Kettering Cancer Center. Started May 2017; status: completed.
02
Drugs
isavuconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT03149055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03149055.